Patient experience survey
Results and analysis from the 2019 National Cancer Patient Experience Survey for London CCGs
The National Cancer Patient Experience Survey aims to improve a patient’s experience of their cancer care and to inform commissioners and service providers about the cancer patients’ experience.
The Transforming Cancer Services Team for London has published an analysis of the results from the 2019 National Cancer Patient Experience Survey for each London CCG and STP to help support commissioners in their work to improve cancer care for patients.
The 2019 survey was sent to all NHS patients 16 and over who had received a confirmed primary diagnosis of cancer or been discharged from an NHS Trust after an inpatient episode or day case attendance for cancer related treatment in April, May and June 2019.
The Transforming Cancer Services Team has produced an interactive dashboard which includes reports on the results and analysis for each London CCG as well as for the corresponding STPs.
The dashboard enables commissioners, clinical leaders and the public to have an understanding of the cancer patient experience in their locality by reviewing the patient experience data alongside the qualitative analysis.
National survey background
The national survey was sent out between December 2019 and March 2020.
Questionnaires were sent by post with two reminders where necessary, with an option to complete online. A Freephone helpline was available to provide access to a translation and interpreting facility.
The national survey has been running since 2010 however the 2019 results should only be compared with the results of the 2015 – 2018 surveys, due to major changes to the questions and scoring to the previous surveys.
The 2019NCPES Trust and CCG results were released on 25th June 2020 and are designated Official Statistics.
The TCST analysis of the results and recommendations regarding the results are displayed on Tableau; an online data visualisation tool. The analysis and data is available for each CCG, Sustainability and Transition Partnership (STP) and Cancer Alliance in London.
There are 52 scored questions on the survey.
Unadjusted data is used in this report as this scoring shows actual patient percentage scores.
For unadjusted and adjusted scores at national, Trust, CCG and Cancer Alliance levels, when the base size per question was< 21, the score was suppressed and replaced with an asterisk(*).The base size included only positive and negative response options.
Where results are presented at response option level, questions where the number of respondents selecting a given option was not 0 but less than 6weresuppressed and replaced with an asterisk(*).This is to minimise the risk that the results could be disclosed. All other response options, which could be used to calculate the suppressed number, was also suppressed. This suppression rule did not apply to all neutral response options
The following questions scores are not published: 3, 4, 8, 9, 26, 29, 42, 45, 48.
National Cancer Patient Experience Survey 2015 – 2019 (and available to view below).